Strategies for Incorporating OD Prevention Into Your Work Eliza Wheeler Drug Overdose Prevention & Education (DOPE) Project Harm Reduction Coalition 510.444.6969.

Slides:



Advertisements
Similar presentations
Daliah Heller, PhD, MPH Assistant Commissioner
Advertisements

Sharon Stancliff, MD Caroline Rath, PA-C Harm Reduction Coalition New York, NY USA.
The Regulatory Perspective
Cindy Powers Magrini, PharmD, BCPS
Deaths Avoided With Naloxone What is Naloxone? Naloxone commonly known as Narcan is a medication that can reverse and overdose caused by an opioid drug.
Identifying the Prevalence of Perinatal Substance Abuse in Santa Clara County September 2004 Karen Miyamoto, PHN Maternal, Child & Adolescent Health Program.
Project Coordinator Overdose Prevention Project, Prevention Point Pittsburgh Alice Bell, LCSW.
Opioid Safety Phillip Coffin, MD, MIA Director of Substance Use Research San Francisco Dept. of Public Health Assistant Clinical Professor University of.
Syringes in Paradise Over 20 Years of Syringe Exchange in Hawai ʿ i Heather Lusk CHOW Project
Overview of Syringe Exchange Programs New York City Police Academy November 24, 2004.
The Take Home Naloxone Program in British Columbia, Canada Erin Gibson, Despina Tzemis, Jane Buxton BC Centre for Disease Control Harm Reduction Program.
North Dakota Pilot Community Paramedic Project. Community Paramedics in N.D., Why? Inconsistent Access to Healthcare in State Insufficient providers at.
© 2007 McGraw-Hill Higher Education. All rights reserved. 1 School Health Services: Promoting and Protecting Student Health Chapter 2.
Implementation in Ohio’s Regional Psychiatric Hospitals.
Injection drug users’ knowledge about overdose prevention and take home Naloxone in Ukraine. ICF 'International HIV/AIDS Alliance in Ukraine Liudmyla Shulga.
Working with SEPs: How do we expand Hepatitis Services ? Narelle Ellendon, RN HCV Director Harm Reduction Coalition, NYC
HIV/AIDS prevention and care among injecting drug users and in prison settings in Estonia, Latvia and Lithuania Signe ROTBERGA UNODC, Baltic States 5 November.
The Governance of Care: Mapping Local Influences on IDU Health Interventions in a Polish City Sobeyko J (1)(8), Leszczyszyn-Pynka M (1)(2), Duklas T (7),
Naloxone (Narcan) A true opioid overdose antidote.
Recommendations on the Management of Opioid Overdose Ruth Birgin.
Prescription Drug Monitoring Programs: Analysis of State Level Usage Requirements Matthew Penn, JD, Carla Chen, JD Director, Public Health Law Program.
John R. Kasich, Governor Tracy J. Plouck, Director Andrea Boxill, MA Deputy Director 2/23/20151.
Pinellas Safe Start Evaluation Prepared by Sandra Ortega For the 2004 Cross-Site Meeting Baltimore, MD November 2004.
Rx for Success Next Steps to Prevent Prescription Drug Abuse Rebecca Hebner, MPH Substance Abuse Prevention Systems Coordinator.
Community Policing. Developed in Response ● To the changes that put police in cars and removed them from neighborhoods ● To understanding that modern.
Quaboag Hills Community Coalition Substance Use Task Force October 20, 2014 Overview of the Strategic Prevention Framework (SPF) “Road Map” What are Evidence-Based.
Overdose: A major preventable cause of death in Eastern Europe and Central Asia Shona Schonning.
MEDLINEPLUS AND AFFORDABLE CARE ACT RESOURCES Lydia N. Collins Consumer Health Coordinator National Network of Libraries of Medicine, Middle Atlantic Region.
Reimbursement Nutr 564: Summer Objectives n Identify the components of reimbursement n Describe the barriers n Identify resources for MNT reimbursement.
Introduction Research indicates benefits to companies who establish effective worker safety and health programs: –Reduction in the extent and severity.
University of Wisconsin Pain & Policy Studies Group World Health Organization Collaborating Center for Pain Policy and Palliative Care Action Plan for:
1 Statewide Screening Collaborative July 30, 2013 Prevention Resource and Referral Services (PRRS) Susan Roddy, PRRS Project Director.
1 The Health Team HST 2 2 Introduction Care of the sick, the prevention of illness and the promotion of health and general welfare requires a combination.
Trends in Opioid Use and Overdose in BC: Making the case for greater availability of Take Home Naloxone programs Ashraf Amlani Harm Reduction Epidemiologist.
The Pink Palace NEX for the 21 st Century. “I’ve got a taxi waiting…” One at a time Physical space unwelcoming and uncomfortable for users and workers.
Health Delivery Services May 29, Eastern Massachusetts Healthcare Initiative Policy Work Group Session 2 May 29, 2009.
Chapter 7.2 Examination and Treatment Prepared by Nguyen Trong Khoa.
Prevention, Enforcement and Treatment (PET) Program NH Provider’s Association Annual Conference Eric Adams, PET Coordinator Laconia Police Department October.
1 December 8, 2015 Crista M. Taylor, LCSW-C Director, Information, Planning and Development Adrienne Breidenstine, MSW Director of Opioid Overdose Prevention.
Accreditation of health practitioners in Russia starting from 2016: answers to frequently asked questions.
Naloxone nasal spray in Norway Thomas Clausen Professor (Dr. med) 5. November 2015.
Large numbers of ill people seek care; EDs, clinics, and medical offices are crowded; there’s a surge on medical facilities; Delays in seeing a provider;
Public Libraries: Iowa City Public Library created the Expanding Access to Consumer Health Electronic Resources Program with help from a grant from the.
Collaborative Community Based Strategies for Addressing Fall Prevention October 2012 April R. Vince LSW, MSSA Cuyahoga County Board of Health.
Naloxone for Entities & Laysavers Aaron Kochar, J.D.
Strategies to overcome barriers to communication To ensure good communication in a Health and/or Social Care setting.
Bystander Naloxone Training Saves Lives. Death rates are spiraling out of control--for both prescription opioids and heroin! Graphic: Nytimes.com.
Overdose Prevention Pilot Project Cross Systems Collaboration. Naloxone Distribution In cooperation with LA Community Health Project June 4, 2014, VCBH,
Community Awareness and Prevention Association. Problem Statement Root Causes But Why? Local Conditions But Why Here? Non - Medical use of Prescription.
Non-Medical Staff Knowledge, Beliefs and Practices about HIV and Hepatitis for Injection Drug Users Rowe, KA 1, Tesoriero, JM 1, Heavner, KK 1, Rothman,
Drug-related deaths Phil Conley Health Improvement Programme Manager September 2015.
Reimbursement Nutr 564: Summer Objectives n Identify the components of reimbursement n Describe the barriers n Identify resources for MNT reimbursement.
or you can use Text Voting by texting ”nmpha” to 22333
Hepatitis C Virus Program in Chicago
The Aviator Hotel – South Africa Uganda Harm Reduction Network (UHRN)
Outline Overdose preparedness at your organization
Transitional Grant Area
COLLECTIVE IMPACT APPROACH TO ADDRESSING
Current harm reduction program at outreach
An overdose Reduction PlaN
Henry L. Dorkin, MD, FAAP President, Massachusetts Medical Society
Opioid Overdose Responder Training
Experiences from a national overdose prevention strategy: Nasal naloxone distribution and lessons learned Philipp Lobmaier, MD, PhD Norwegian Centre.
Steve Alsum The Grand Rapids Red Project
Opioid-related harms and responses
QC Harm Reduction Opioid Overdose Reversal Training
Prescription Drug Overdose (PDO) Grant Data collection in New Mexico
Naloxone in North Carolina
Town of Collingwood Council September 10th, 2018 Mia Brown RN BScN
Human Dignity and Harm Reduction
Presentation transcript:

Strategies for Incorporating OD Prevention Into Your Work Eliza Wheeler Drug Overdose Prevention & Education (DOPE) Project Harm Reduction Coalition x 16

Overdose Prevention & Naloxone Distribution Programs in the U.S. The earliest naloxone distribution began in 1996 and some programs started as recently as this year. States authorizing naloxone distribution: New York, New Mexico, Massachusetts, Illinois California has passed legislation to provide additional liability protection in 7 counties as a “pilot.” Cities, counties, local health departments, and individual programs have implemented naloxone distribution.

Overdose Prevention & Naloxone Distribution Programs in the U.S. As of November 2010, there were 189 sites where naloxone distribution was happening in 15 U.S. States and the District of Columbia. 67 % distribute 10ml vials of naloxone 42% distribute 1ml vials of naloxone 17% distribute 2ml Intranasal naloxone **Percentages equal more than 100% because some programs distribute multiple formulations of naloxone, or have had different types throughout the years.

Overdose Prevention & Naloxone Distribution Programs in the U.S. Between 1996 and June 2010, a total of 53,339 individuals have been trained and given naloxone as a result of US naloxone distribution programs. Programs have received reports of 10,194 overdose reversals using naloxone. 38,860 units of naloxone (all types) have been distributed during the last year, from July 2009-June 2010.

Common barriers to implementing an OD Prevention Program: Liability concerns Resources and time Agency policies Community opposition Ideological differences, lack of buy-in to Harm Reduction model

Common concerns and criticisms of OD prevention programs: Drug users are not capable of recognizing and managing an OD with naloxone The person who gets naloxone will be violent upon OD reversal Naloxone access will postpone peoples’ entry into drug treatment Naloxone access encourages riskier drug use

Integrating overdose messages Informal conversations that explore the context of drug use (i.e. do you use alone in your hotel room? Do you have friends who live nearby who know you use?) Adding assessment questions about overdose risk Including OD prevention as part of treatment plans/goal setting/discharge planning Posting OD-related messages (i.e. “Ask me about OD Prevention”)

Integrating Overdose Messages How do we talk with participants about their overdose risk or history of overdose? How do we provide overdose education in our setting(s)? Are there any programmatic barriers to communication (i.e. abstinence requirements, clients fear losing services if they disclose drug use, staff attitudes)? Is staff prepared to discuss harm reduction options with participants?

Providing OD Response Trainings Overdose prevention and response trainings can be done even if you are not yet able to distribute Naloxone Education on Rescue Breathing, calling an ambulance and other basic first aid response can be lifesaving Incorporate into existing group meetings and one- on-one interactions with participants Cost: staff time and printing materials, optional: rescue breathing mouth shields and rescue breathing dummies

Overdose Prevention, Recognition, and Response Training

Overdose Prevention, Recognition, & Response Trainings Can be done in various settings and using different models 10 minutes  60 minutes in length Depends on setting and experience of trainees Groups, pairs, individuals

Components of a Training 1. What is an overdose? 2. What causes an overdose? 3. Prevention messages 4. Recognition 5. Response 6. Aftercare

Naloxone Distribution Can we do it?

How is naloxone distributed? Distribution—programs obtain supply of naloxone and distribute to participants without prescriptions or medical provider oversight. Standing Order—issued by Health Department or physician to empower health care providers like nurse practitioners or trained outreach staff to distribute naloxone Prescription—program has medical provider sign off on a prescription for individuals who participate in a training and complete a short medical history/clinical registration form, health care professional must be present or available to sign prescriptions.

Pros and Cons of Distribution: Pros: Gets naloxone to the people who need it, without having to wait for “official” approval. Less paperwork, lower threshold Cons: Limited resources or funding to support program or purchase supplies Potentially inconsistent supply of naloxone Could put program and/or individuals distributing naloxone at risk for “practicing medicine without a license.” Could put program participants at risk for arrest for carrying prescription medication without documentation that it was prescribed to them

Pros and Cons of Prescriptions: Pros Protects participants from arrest for possession of a prescription drug without a prescription Documentation (paper trail) protects prescribing medical professional in terms of liability Cons Higher threshold (more paperwork required) Some medical providers still wary of providing naloxone in this manner Technically, provider must be present when naloxone is distributed, which requires time and resources Limited availability of providers can mean limited times that naloxone can be distributed.

Pros and Cons of Standing Orders: Pros Allows programs more freedom to distribute naloxone without the need for a medical professional on-site at the time of the trainings In states like Massachusetts, the Standing Order actually empowers NON-medical staff (i.e. NEX workers) to distribute naloxone Cons Unclear if Standing Orders are legally feasible for naloxone distribution, has not been legally “tested.” Medical providers can be skeptical of using Standing Orders and may want more oversight of the program if their license is on the line

Start a Naloxone Program! Identify the scope of the overdose problem in your community (what drugs, who, where, etc.) Find a medical director or licensed physician that is willing to prescribe naloxone (cite research, enabling laws and put in touch with currently prescribing doctors and medical directors). Purchase naloxone (with MD’s license number, through pharmacy or health department) and other supplies for kits.

Start a Naloxone Program! Train program participants, satellite exchangers, peer educators, outreach workers, health educators, etc. who can do the overdose prevention and response trainings. Work on getting community buy-in, especially first- responders like ambulance workers and police to prevent confiscation and harassment Network with prisons, drug treatment, parents groups, etc. to expand distribution

Considerations: Given your agency's facilities, policies, and staff, what are the potential barriers to developing an overdose prevention plan? What training would your agency need in order to put your plan into action? What resources do you already have (space, staff, time, photocopier, etc.)? And what do you need?

Thank You Eliza Wheeler DOPE Project Harm Reduction Coalition x 16